About
Technology
Issues
FAQ
Links
Official Page
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.